What's in Gruppo Italiano Trapianto di Midollo Osseo's pipeline?

Gruppo Italiano Trapianto di Midollo Osseo has 4 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Gruppo Italiano Trapianto di Midollo Osseo's portfolio?

Top competitors by shared drug class: Tel-Aviv Sourasky Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/gruppo-italiano-trapianto-di-midollo-osseo.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Gruppo Italiano Trapianto di Midollo Osseo — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gruppo Italiano Trapianto di Midollo Osseo pipeline: 0 marketed, 0 filed, 2 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Busulphan plus Fludarabine	Busulphan plus Fludarabine	phase 3	Alkylating agent + Antimetabolite combination		Oncology
Busulphan plus Cyclophosphamide	Busulphan plus Cyclophosphamide	phase 3	Alkylating agents		Oncology

Therapeutic area mix

Oncology · 2
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Tel-Aviv Sourasky Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Gruppo Italiano Trapianto di Midollo Osseo:

Cite this brief

Drug Landscape (2026). Gruppo Italiano Trapianto di Midollo Osseo — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gruppo-italiano-trapianto-di-midollo-osseo. Accessed 2026-05-17.